The EPS projection of Evolent Health Inc (NYSE:EVH) for period quarter completed 2016-12-31 is $-0.14.
The EPS estimates given a week and 30-days ago were $-0.14 and $-0.14 correspondingly. This number 60 and 90 days before was $-0.14 and $-0.14 respectively. However, over last week ago, the change in EPS estimate is 0%.
For the quarter completed 2 mean estimate is $-0.14 based on 7 EPS estimations. As on 2016-08-04 estimated EPS stood at $-0.25 showing surprise of $-0.09, or -56.25%. Following the disclosed forecasts, the standard deviation is $0.01.
The upgrade in EPS revisions were 0 a week earlier against negative revisions of 0. In last 1- month and 60-days, the upgrade in EPS revisions were 0 and 0 correspondingly, whereas for a quarter and 120-days earlier, it was 4 and 4 in that sequence.
The negative revisions of earnings per-share in the last 1-month and 60-days were 1 and 1 in that order. However, a quarter and 120-days earlier, this count was 1 and 1 correspondingly.
EPS revisions downgrade and upgrade in the last 18 days were 2 and 1, correspondingly.
Quarterly Sales Estimates
The arithmetic mean of apparent annual sales of Evolent Health Inc (NYSE:EVH) is $63.337 and the median is $60.7. The estimate is stated by 7 analysts for the fiscal 2016.
The highest yearly projection is $80.6 and lowest sales mark is $59.1. This results a standard deviation of $7.638.
Almost 7 have revised sales target positively in the past week and 7 have downgraded forecasts. Depending on the stated estimates, the calculated change in target against the past week is 0%.
Nearly 7 revised sales projections positively over the past month and 7 have downgraded forecasts. It leads to a mean estimate deviation of 4.874%.
Just about 7 have revised sales forecast positively over the quarter and 7 have downgraded forecasts, giving a deviation of 5.501%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...